News

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
Although Merck (NYSE:MRK) is confronted with the unavoidable Keytruda patent cliff in 2028, the company is strategically ...
Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.
Mr Kennedy is what is known politely as a “vaccine sceptic” and impolitely as a crank. He is undermining trust in, sensible ...